Business Context and Reporting Period
This Form 8-K was filed by Greatbatch, Inc. on May 28, 2014. The filing announces a strategic plan to enhance vascular and portable medical manufacturing operations by consolidating facilities. The company intends to transfer manufacturing functions from Plymouth, Minnesota; Beaverton, Oregon; and Raynham, Massachusetts to existing and new facilities in Tijuana, Mexico.
Key Financial Metrics
The filing details projected costs and investments related to the restructuring plan rather than historical financial performance.
- Restructuring Charges: Expected between $17.0 million and $22.0 million over the next two years.
- Severance and Termination Benefits: Estimated between $6.0 million and $8.0 million.
- Asset Write-offs and Depreciation: Estimated between $1.5 million and $2.0 million.
- Relocation and Disposal Costs: Estimated between $9.5 million and $12.0 million.
- Capital Investment: Expected between $17.0 million and $19.0 million.
- Projected Annual Cost Savings: Anticipated in the range of $15.0 million to $17.0 million post-completion.
The filing text does not provide clear values for current revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change is the initiation of a restructuring plan involving the closure or consolidation of three U.S. manufacturing sites and the expansion of operations in Mexico. This will result in significant one-time charges and capital expenditures over the next two years.
Guidance, Outlook, and Risks
Management views this consolidation as a strategic objective to achieve profitable growth. The plan is scheduled for completion by the first half of 2016 for the Plymouth facility and by the end of 2015 for the Beaverton and Raynham facilities. The filing notes that all expenses are expected to be cash expenditures, with the exception of accelerated depreciation and asset write-offs. No specific risks or contingencies beyond the execution of the plan are detailed in this text.
Investor Verification Checklist
- Verify the timeline for facility closures in Plymouth, Beaverton, and Raynham against the stated 2015-2016 deadlines.
- Monitor quarterly earnings reports for the recognition of the $17.0 million to $22.0 million in restructuring charges.
- Track capital expenditure reports to confirm the $17.0 million to $19.0 million investment in the new Tijuana facility.
- Assess whether the projected annual cost savings of $15.0 million to $17.0 million are realized in future operating margins.